2022
DOI: 10.1016/j.ejmech.2022.114324
|View full text |Cite
|
Sign up to set email alerts
|

Discovery of spirooxadiazoline oxindoles with dual-stage antimalarial activity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
7
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 13 publications
(9 citation statements)
references
References 44 publications
1
7
0
Order By: Relevance
“…Some of the synthesized spirooxindoles reveal promising properties against erythrocytic stage of P. falciparum and the liver-stage of P. berghei . This supports the possibility of developing active agents inhibiting both blood-stage and ( P. falciparum ) and liver-stage ( P. berghei ) parasites [ 65 ].…”
Section: Synthetic Spirooxindolessupporting
confidence: 60%
“…Some of the synthesized spirooxindoles reveal promising properties against erythrocytic stage of P. falciparum and the liver-stage of P. berghei . This supports the possibility of developing active agents inhibiting both blood-stage and ( P. falciparum ) and liver-stage ( P. berghei ) parasites [ 65 ].…”
Section: Synthetic Spirooxindolessupporting
confidence: 60%
“…Despite several initiatives to reduce the incidence of protozoan disease, including treatment of giardiasis with the antibiotic metronidazole ( 13 ); treatment of malaria with artemisinin ( 14 ); and improvements in water, sanitation and hygiene conditions, protozoan infection remains a serious global health concern. Furthermore, drug resistance is a growing problem in veterinary medicine and may develop in humans; for example, metronidazole resistance has been reported in Endamoeba histolytica ( E. histolytica ) ( 15 ), Trichomonas vaginalis ( T. vaginalis ) ( 16 ) and G. lamblia ( 17 ).…”
Section: Introductionmentioning
confidence: 99%
“…[13] Screening of large corporate libraries, such as the Tres Cantos Antimalarial Set (TCAMS) from GSK, [14] also identified novel indole-based antimalarials that were used as starting points for the development of the next generation antimalarial lead compounds, such as 3-piperidin-4-yl-indoles 2. [15] Many other indole-related antimalarial chemotypes, including indoloquinolines 3, [16] indolizinoindolones 4, [17,18] indole-containing pyrazino[2,1b]quinazoline-3,6-diones 5, [19] and spirooxadiazoline oxindoles 6 [20] have emerged from academic settings.…”
Section: Introductionmentioning
confidence: 99%